Article Text
Therapuetics
Review: pioglitazone does not reduce risk of mortality or cardiovascular events in type 2 diabetes
Statistics from Altmetric.com
Footnotes
-
For correspondence: Dr B Richter, Universitaetsklinikum Duesseldorf, Duesseldorf, Germany. richterb{at}uni-duesseldorf.de
-
Source of funding: no external funding.